Seeing Is Believing
Currently out of the existing stock ratings of Eun Yang, 93 are a BUY (72.66%), 30 are a HOLD (23.44%), 5 are a SELL (3.91%).
Analyst Eun Yang works at JEFFERIES with a stock forecast success ratio of 54.38% fulfilled within 234.21 days on average.
Eun Yang’s has documented 248 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AVTE, Aerovate Therapeutics at 25-Mar-2024.
Analyst best performing recommendations are on CNTA (CENTESSA PHARMACEUTICALS PLC ADR).
The best stock recommendation documented was for RIGL (RIGEL PHARMACEUTICALS) at 6/8/2022. The price target of $1 was fulfilled within 9 days with a profit of $0.3 (42.86%) receiving and performance score of 47.62.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
42
$-2.15 (-4.87%)
42
1 years 2 months 9 days ago
0/15 (0%)
$-2.18 (-4.93%)
Buy
42
$-2.15 (-4.87%)
82
1 years 3 months 13 days ago
0/4 (0%)
$-2.1 (-4.76%)
Buy
42
$-2.15 (-4.87%)
68
1 years 3 months 13 days ago
0/3 (0%)
$-2.1 (-4.76%)
Hold
55
1 years 3 months 13 days ago
0/1 (0%)
$36.77 (201.70%)
Hold
42
$-2.15 (-4.87%)
61
1 years 3 months 15 days ago
0/2 (0%)
$-1.85 (-4.22%)
Which stock is Eun Yang is most bullish on?
Which stock is Eun Yang is most reserved on?
What Year was the first public recommendation made by Eun Yang?